
MREO
Healthcare · Biotechnology · $49.1M market cap
$0.3075+0.00 (+0.8%)Nov 13, 4:00 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +18.6% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 18, 2027 · upcoming | Before the open | -0.01 | — | — |
| Nov 9, 2026 | Before the open | -0.01 | -0.01 | 0.0% |
| Aug 11, 2026 | Before the open | -0.01 | -0.01 | 0.0% |
| Apr 1, 2026 | Time not confirmed | -0.01 | -0.01 | +43.4% |
| Mar 19, 2026 | Before the open | -0.01 | -0.01 | 0.0% |
| Nov 10, 2025 | After the close | 0.01 | -0.01 | -175.2% |
| Aug 12, 2025 | Before the open | -0.01 | -0.01 | 0.0% |
| May 13, 2025 | Before the open | -0.01 | -0.02 | -100.0% |
| Mar 26, 2025 | Time not confirmed | -0.01 | -0.01 | 0.0% |
| Nov 12, 2024 | Before the open | -0.01 | -0.02 | -100.0% |
| Aug 13, 2024 | Before the open | -0.01 | -0.02 | -100.0% |
| May 15, 2024 | After the close | -0.01 | -0.06 | -539.0% |
| Mar 27, 2024 | Time not confirmed | -0.02 |
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and…
| -0.01 |
| +25.0% |
| Nov 17, 2023 | After the close | 0.00 | 0.00 | — |
| Sep 7, 2023 | Before the open | -0.02 | -0.02 | 0.0% |
| May 31, 2023 | Time not confirmed | — | 0.00 | — |
| Mar 28, 2023 | After the close | -0.02 | -0.02 | 0.0% |
| Nov 1, 2022 | After the close | -0.02 | 0.06 | +400.0% |
| Mar 30, 2022 | After the close | -0.03 | -0.17 | -466.7% |
| Aug 11, 2021 | Time not confirmed | -0.14 | 0.00 | +100.0% |
| Jun 2, 2021 | Time not confirmed | -0.14 | -0.14 | +0.5% |
| Mar 31, 2021 | After the close | 0.00 | 0.08 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | -0.24 | — |
| Sep 29, 2020 | Before the open | 0.00 | -0.23 | — |
| Jun 15, 2020 | After the close | -0.26 | -3.28 | -1160.4% |
| Mar 31, 2020 | Time not confirmed | 0.00 | -3.29 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.59 | — |
| Sep 17, 2019 | Before the open | 0.00 | -0.54 | — |
| Apr 29, 2019 | Before the open | 0.00 | -0.70 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.72 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.67 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | -0.69 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.79 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.84 | — |